Minaris (WuXi Advanced Therapies)
Philadelphia, PA / Yokohama, Japan
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
60.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Minaris (WuXi Advanced Therapies)
- Signal Score
- 60.5/100 (as of 2026-09-07)
- Quality Compliance
- Assessment pending
- Headquarters
- Philadelphia, PA / Yokohama, Japan
- Modalities
- CAR-T, Cell Therapy
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Minaris (WuXi Advanced Therapies)
BIOSECURE Act risk.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
58.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
63.0
Profile-based capacity assessment
Frequently Asked Questions About Minaris (WuXi Advanced Therapies)
What is Minaris (WuXi Advanced Therapies)'s CDMO Signal Score?
Minaris (WuXi Advanced Therapies) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Minaris (WuXi Advanced Therapies) for a manufacturing program?
Use the free AI matchmaker to compare Minaris (WuXi Advanced Therapies) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.3
CAR-T, Cell Therapy
Hitachi Global Life Solutions (CGT)
Yokohama, Japan
Signal Score: 63.0
Cell Therapy, CAR-T
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 91.1
CAR-T, Cell Therapy
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 83.9
CAR-T, Cell Therapy